FHS Nigeria
•Download as PPT, PDF•
1 like•388 views
I
IDSThis presentation was Oladimeji Oladepo of the University of Ibadan at a Future Health Systems conference in Abuja, Nigeria, in January 2009. www.futurehealthsystems.org.
Report
Share
Report
Share
![Research Question ,[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Medicines Transparency In Ghana
Presentation on the medicines supply system in Ghana at the launch of the Medicines Transparency Alliance, London May 2008
Challenges to improve medicines transparency in Ghana
This is a presentation by Dr Daniel Kojo Arhinful at the launch of the Medicines Transparency Alliance (MeTA) in Ghana in November 2008. MeTA is a global alliance, working in 7 pilot countries. For more information, see www.MedicinesTransparency.org
Governance, transparency and Accountability~ MeTA objectives, approaches and ...
Presentation by Daniel Kojo Arhinful on Governance, transparency and Accountability~ MeTA objectives, approaches and role of CSOs, during the MeTA Ghana, CSOs and media orientation workshop, on 16 April 2009.
Pharmacare 2.0 initiative
This document discusses CPhA's Pharmacare 2.0 initiative to build consensus around improving Canada's pharmacare system. It provides an overview of Canadians' views and experiences with medication access and affordability. CPhA's principles for pharmacare emphasize access, safety, and sustainability. The document reviews potential pharmacare models and considers their costs, benefits, and drawbacks. It argues for an incremental, patient-focused approach to pharmacare that addresses coverage gaps while supporting optimal drug therapy.
SARET_mHealthPrivacy_Aug2015
Research staff administered a 72-item survey to 85 patients at an inpatient detoxification program between December 2014 and July 2015. The survey assessed technology use, mHealth adoption preferences, and privacy concerns regarding mHealth for addiction treatment. Results found that participants' technology use patterns were consistent with nationwide trends, though they expressed added sensitivity to privacy of text message content. While most participants were open to using mHealth apps for recovery support, many had privacy concerns about substance use terminology being visible to others. The study highlights both opportunities and privacy challenges regarding tailored mHealth interventions for addiction treatment.
CSO & media orientation workshop
Presentation by Dr Alex Dodoo, Co-chair, MeTA Ghana during the MeTA Ghana CSO & media orientation workshop, 16 April 2009.
Federal Election Special - What are the Parties Saying About Healthcare and C...
Federal Election Special - What are the Parties Saying About Healthcare and C...Canadian Cancer Survivor Network
The document summarizes the federal parties' stances on health and oncology policy based on their responses to questions from the Canadian Cancer Survivor Network (CCSN). The Conservative Party had not yet provided any answers. The Liberal Party, NDP, and Bloc Quebecois provided responses supporting expanding employment insurance sickness benefits, improving access to disability benefits, and working with provinces on a national pharmacare program. The Liberal Party and NDP emphasized increasing healthcare funding and leadership. The Green Party had not yet responded.Awareness of Filipino Community Pharmacists on Immunization Delivery: A Key f...
As provided for by Republic Act No. 10918, there is an impending need to train community pharmacists in the provision of direct immunization services in the community, in addition to their perceived roles in dispensing and patient counselling. This study seeks to identify problem areas that limit or impede the roles of community pharmacists in the actual administration of routine adult vaccines. A validated semistructured questionnaire based on the Likert scale was designed to assess respondent pharmacists in the areas of dispensing, information systems, vaccine administration and perception on the general concepts of immunization. The respondents highly agreed that they have sufficient information concerning delivery of immunization services in the community and are highly receptive to the provisions of appropriate trainings in vaccine administration. However, there are further needs for trainings on safe and effective parenteral vaccine administration and delivery as well as good dispensing practices for biological products. This study shows that there is a strong need for community pharmacists to be aware and participate in training programs focusing on direct vaccine administration and adverse reaction counselling
Recommended
Medicines Transparency In Ghana
Presentation on the medicines supply system in Ghana at the launch of the Medicines Transparency Alliance, London May 2008
Challenges to improve medicines transparency in Ghana
This is a presentation by Dr Daniel Kojo Arhinful at the launch of the Medicines Transparency Alliance (MeTA) in Ghana in November 2008. MeTA is a global alliance, working in 7 pilot countries. For more information, see www.MedicinesTransparency.org
Governance, transparency and Accountability~ MeTA objectives, approaches and ...
Presentation by Daniel Kojo Arhinful on Governance, transparency and Accountability~ MeTA objectives, approaches and role of CSOs, during the MeTA Ghana, CSOs and media orientation workshop, on 16 April 2009.
Pharmacare 2.0 initiative
This document discusses CPhA's Pharmacare 2.0 initiative to build consensus around improving Canada's pharmacare system. It provides an overview of Canadians' views and experiences with medication access and affordability. CPhA's principles for pharmacare emphasize access, safety, and sustainability. The document reviews potential pharmacare models and considers their costs, benefits, and drawbacks. It argues for an incremental, patient-focused approach to pharmacare that addresses coverage gaps while supporting optimal drug therapy.
SARET_mHealthPrivacy_Aug2015
Research staff administered a 72-item survey to 85 patients at an inpatient detoxification program between December 2014 and July 2015. The survey assessed technology use, mHealth adoption preferences, and privacy concerns regarding mHealth for addiction treatment. Results found that participants' technology use patterns were consistent with nationwide trends, though they expressed added sensitivity to privacy of text message content. While most participants were open to using mHealth apps for recovery support, many had privacy concerns about substance use terminology being visible to others. The study highlights both opportunities and privacy challenges regarding tailored mHealth interventions for addiction treatment.
CSO & media orientation workshop
Presentation by Dr Alex Dodoo, Co-chair, MeTA Ghana during the MeTA Ghana CSO & media orientation workshop, 16 April 2009.
Federal Election Special - What are the Parties Saying About Healthcare and C...
Federal Election Special - What are the Parties Saying About Healthcare and C...Canadian Cancer Survivor Network
The document summarizes the federal parties' stances on health and oncology policy based on their responses to questions from the Canadian Cancer Survivor Network (CCSN). The Conservative Party had not yet provided any answers. The Liberal Party, NDP, and Bloc Quebecois provided responses supporting expanding employment insurance sickness benefits, improving access to disability benefits, and working with provinces on a national pharmacare program. The Liberal Party and NDP emphasized increasing healthcare funding and leadership. The Green Party had not yet responded.Awareness of Filipino Community Pharmacists on Immunization Delivery: A Key f...
As provided for by Republic Act No. 10918, there is an impending need to train community pharmacists in the provision of direct immunization services in the community, in addition to their perceived roles in dispensing and patient counselling. This study seeks to identify problem areas that limit or impede the roles of community pharmacists in the actual administration of routine adult vaccines. A validated semistructured questionnaire based on the Likert scale was designed to assess respondent pharmacists in the areas of dispensing, information systems, vaccine administration and perception on the general concepts of immunization. The respondents highly agreed that they have sufficient information concerning delivery of immunization services in the community and are highly receptive to the provisions of appropriate trainings in vaccine administration. However, there are further needs for trainings on safe and effective parenteral vaccine administration and delivery as well as good dispensing practices for biological products. This study shows that there is a strong need for community pharmacists to be aware and participate in training programs focusing on direct vaccine administration and adverse reaction counselling
Tobacco cessation Therapy, India, Marketing strategy
This document outlines a plan to build tobacco cessation infrastructure in India. It discusses establishing brand awareness for nicotine replacement therapy gum to help smokers quit. The plan involves educating doctors and the public, identifying key customer groups, building training and support infrastructure at clinics, and implementing a marketing strategy using various channels. Challenges include lack of resources, access issues, social stigma, and existing competitors in the nicotine replacement space.
Patient Centricity in Pharmacovigilance: New Directions and New Horizons for ...
The importance of pharmacovigilance (PV) as a science, critical to both effective patient care in clinical practice and public health is growing. **Disclaimer: This article was previously published. Sciformix is now a Covance company.
Parthvora123
This document discusses essential medicines concepts. It defines essential medicines as those that satisfy the priority health needs of populations and should be accessible at all times in sufficient amounts at generally affordable prices. Essential medicines are carefully selected based on disease prevalence, public health relevance, efficacy, safety, and cost-effectiveness. The document outlines the history of essential medicines lists since 1977 and roles of various stakeholders. Factors affecting implementation include pricing, availability, reimbursement, infrastructure, and patents. National essential medicines lists guide treatment, promote rational drug use, and optimize health resources.
Il processo di innovazione in atto: dalle strategie di brevettazione al fundr...
L'intervento di Luca Pani (professore Ordinario di Psichiatria Clinica, Università di Miami) in occasione dell'evento "Il valore della ricerca biomedica" che si è tenuto a Pula (CA) il 3 aprile 2019.
Telepharmacy
Telepharmacy involves delivering pharmaceutical care via telecommunications to patients who may not have direct contact with a pharmacist. It allows pharmacists to actively provide pharmacy services from a distance through technologies like store-and-forward messaging, remote patient monitoring, and mobile care. Telepharmacy can increase access to healthcare for underserved populations, reduce costs, and save travel time for both providers and patients. While it faces challenges like acceptance of the technology and technical constraints, telepharmacy holds promise for improving access to pharmaceutical care for people in rural and remote communities.
Direct-to-Consumer Advertising in the Digital Age
This document discusses the increasing role of social media and the internet in the promotion of prescription drugs in Canada. It notes that pharmaceutical companies are shifting marketing budgets from traditional to digital channels due to cost pressures. The document outlines Canadian regulations around direct-to-consumer drug advertising and discusses concerns about the effects of such advertising. It also examines how pharmaceutical companies are using social media for targeted marketing and the lack of clear guidelines around these practices.
Webinar: Healthcare in the Federal Budget and How It May Affect Patients
Webinar: Healthcare in the Federal Budget and How It May Affect Patients Canadian Cancer Survivor Network
At this webinar, Steve Sampson (Global Public Affairs) discusses how the upcoming federal budget may contain announcements related to the way healthcare is funded in Canada, including changes to the regulation of pharmaceutical prices. Value for taxpayer money should always be the focus for government, but the need for cost-containment needs to be balanced with access to optimal healthcare innovation for patients.TELEPHARMACY
Telepharmacy involves the delivery of pharmaceutical care via telecommunications to patients who do not have direct contact with a pharmacist. It allows remote dispensing of medications and pharmacist monitoring of drug therapy. While telepharmacy improves access to care in remote areas by reducing travel requirements, it faces challenges in implementation due to lack of uniform regulations, technological limitations in rural areas, and changes to workflow. When actively involving pharmacists, telepharmacy can enhance quality of care by improving medication management and reducing errors.
Origin of healthcare funding models
The document summarizes healthcare systems in the United Kingdom and Germany. It discusses funding models for prescription drugs in England, including Clinical Commissioning Groups (CCGs) and the National Institute for Health and Care Excellence (NICE). It also describes the Cancer Drugs Fund in England and reforms to drug pricing in Germany under the AMNOG process.
LIMITATIONS
This study aimed to determine the barriers encountered by community pharmacists in Nigeria in providing pharmaceutical care. The study found that the key limitations reported by community pharmacists included: lack of skills in pharmaceutical care among pharmacists, poor attitudes towards pharmaceutical care practice, and resource and system-related constraints. Despite these limitations, most community pharmacists expressed strong willingness to adopt pharmaceutical care practices to improve patient outcomes. The study provides information to help address the gaps limiting wider implementation of pharmaceutical care in Nigeria.
Out of Box: Pharma Marketing
This document discusses direct-to-consumer (DTC) advertising of pharmaceutical products. It defines DTC advertising as marketing pharmaceutical products directly to consumers through various media like TV, print, radio, and social media. DTC advertising is meant to educate consumers about medical conditions and available treatments, and works in conjunction with doctors, not in isolation. The document also notes how new media and the internet have expanded consumers' access to health information and enabled the evolution of DTC advertising. Some examples of early DTC advertising campaigns for specific drugs are provided. The document concludes by discussing opportunities for the company Vasu to conduct DTC advertising through educational camps and seminars and targeted product leaflets.
Pain Med 2015 - Westanmo - Opioid Dose Reduction in a VA Health Care
The document describes an initiative at the Minneapolis VA Health Care System to reduce high-dose opioid prescribing through a population-level intervention in primary care. The initiative was associated with substantial reductions in the number of patients prescribed more than 200 mg morphine equivalents per day, from 342 patients (0.65% of unique pharmacy patients) before the initiative to 65 patients (0.12%) after. Overall opioid prescribing and doses also decreased over the study period. Provider surveys found increased agreement after the initiative that opioid dose limits and standards of care were important. The initiative demonstrated that leadership support, clinical pharmacy engagement, and monitoring and feedback to providers can successfully reduce high-dose opioid prescribing at a health system level.
Telepharmacy
The document discusses telepharmacy, which involves delivering pharmaceutical care via telecommunications to patients who may not have direct contact with a pharmacist. It provides an introduction to telepharmacy, outlines its objectives like improving access to healthcare and reducing costs. The document discusses the advantages and disadvantages of telepharmacy, and how it can be implemented. It then covers patient considerations, the process of starting a telepharmacy, license applications, how telepharmacy works, different types of telepharmacy models and concludes that telepharmacy can improve access to pharmaceutical care for rural communities.
Marketing and promotion_facts_071108_final
Pharmaceutical marketing to healthcare providers provides information on new treatment options, but it is only one of many factors that influence prescribing decisions. Surveys find clinical knowledge, patient factors, and insurance policies have greater impacts. Approximately 67% of US prescriptions are for generic drugs, much higher than other countries. While representatives provide information, prescribing is shaped more by clinical guidelines, peers, formularies, and insurers' prior authorization requirements than representative interactions.
Marketing and promotion_facts_071108_final
Pharmaceutical marketing aims to educate consumers and healthcare professionals about new treatments. While some question the value of marketing, it plays an important role in disseminating medical information. Recent changes include voluntary principles for direct-to-consumer ads and a strengthened industry code of ethics. Studies show marketing helps address underdiagnosis and undertreatment by raising disease awareness and prompting patients to see doctors. However, most physicians say clinical knowledge and patient needs strongly influence prescribing over marketing.
Inpud advocacy messsages to be delivered to the unodc meeting january 27 v2
The document discusses advocacy messages for a UNODC meeting on developing guidelines for stimulant use. It recommends:
1) Commending efforts to engage people who use drugs and conducting formative research to understand HIV outbreaks among stimulant users before developing guidelines.
2) Focusing on investigating the context of HIV outbreaks and using action research with clear peer support to understand what is happening.
3) Developing a comprehensive perspective that includes examining different stimulant users and factors contributing to their HIV risk separately.
Telepharmacy
Telepharmacy is delivery of pharmaceutical care via telecommunications to patients in locations where they may not have direct contact with pharmacist. It is an instance of wider phenomenon of telemedicine, as implemented in the field of pharmacy.
Telepharmacy services include drug therapy monitoring, patient counseling, monitoring of formulary compliance with the aid of teleconferencing or videoconferencing.
Telepharmacy services can be delivered at retail pharmacy sites or through hospitals, nursing homes or other medical care facilities.
Rural residents and communities lack easy access to healthcare services often due to geographical and demographical factors.
Telepharmacy holds significant promise as a technology to improve access to pharmaceutical care for people living in rural and remote communities.
Telepharmacy is quickly becoming an integral part of modern pharmacy practice that has the potential to provide quality pharmaceutical services, such as medication management, dispensing, patient counseling, and drug information.
Inherent to the adoption of these practices are legal challenges and pitfalls that need to be addressed. A well-developed system, however, can change the practice of pharmacy that is beneficial to both the rural communities and the hospital or retail pharmacies that deliver these services.
Speakers' bios
This document provides brief biographies of six panelists:
- Glen Doucet is Vice President of Advocacy at Canadian Pharmacists Association with over 23 years of experience in government relations.
- Louise Binder is a health advocate and lawyer who has worked to improve access to HIV/AIDS and cancer treatments for over 20 years.
- Marc-André Gagnon is an Associate Professor researching political economy of pharmaceutical sector including regulatory capture and innovation policy.
- Don Husereau is an Adjunct Professor focusing on evidence-based health policy and economics and chairs health technology assessment standards groups.
- W. Neil Palmer is president of a leading pricing and reimbursement consultancy and adjunct professor teaching on
Trudel Cms Rules 072810[1]
This document summarizes changes from the proposed rule to the final rule for Stage 1 of the Medicare and Medicaid EHR Incentive Program's meaningful use criteria. Key changes included lowering thresholds for some objectives, removing administrative transactions, adding new objectives, and modifying clinical quality measures for eligible professionals. The final rule provided more flexibility for states and clarified various eligibility and reporting requirements.
Rishi vis
This document presents Rishi Visual Identity System and includes examples of typefaces like Rish1,lead your life in different fonts of Times, Haettenschweiler, Constantia, Arial and Antiqua. It also lists the sales, public relations and logistics offices under the heading of invitation and VIP.
How i became the mayor of the west indian labor day parade
The document describes a mayor who mistakenly checked in too early for a Labor Day parade event on Foursquare. Though they checked in on the wrong date, many people still checked in. The mayor considers ways to make use of their position, such as coordinating meetups or providing tips for attendees. The implications suggest for event organizers to check in early to own the venue and provide useful tips for attendees to enhance their experience.
More Related Content
What's hot
Tobacco cessation Therapy, India, Marketing strategy
This document outlines a plan to build tobacco cessation infrastructure in India. It discusses establishing brand awareness for nicotine replacement therapy gum to help smokers quit. The plan involves educating doctors and the public, identifying key customer groups, building training and support infrastructure at clinics, and implementing a marketing strategy using various channels. Challenges include lack of resources, access issues, social stigma, and existing competitors in the nicotine replacement space.
Patient Centricity in Pharmacovigilance: New Directions and New Horizons for ...
The importance of pharmacovigilance (PV) as a science, critical to both effective patient care in clinical practice and public health is growing. **Disclaimer: This article was previously published. Sciformix is now a Covance company.
Parthvora123
This document discusses essential medicines concepts. It defines essential medicines as those that satisfy the priority health needs of populations and should be accessible at all times in sufficient amounts at generally affordable prices. Essential medicines are carefully selected based on disease prevalence, public health relevance, efficacy, safety, and cost-effectiveness. The document outlines the history of essential medicines lists since 1977 and roles of various stakeholders. Factors affecting implementation include pricing, availability, reimbursement, infrastructure, and patents. National essential medicines lists guide treatment, promote rational drug use, and optimize health resources.
Il processo di innovazione in atto: dalle strategie di brevettazione al fundr...
L'intervento di Luca Pani (professore Ordinario di Psichiatria Clinica, Università di Miami) in occasione dell'evento "Il valore della ricerca biomedica" che si è tenuto a Pula (CA) il 3 aprile 2019.
Telepharmacy
Telepharmacy involves delivering pharmaceutical care via telecommunications to patients who may not have direct contact with a pharmacist. It allows pharmacists to actively provide pharmacy services from a distance through technologies like store-and-forward messaging, remote patient monitoring, and mobile care. Telepharmacy can increase access to healthcare for underserved populations, reduce costs, and save travel time for both providers and patients. While it faces challenges like acceptance of the technology and technical constraints, telepharmacy holds promise for improving access to pharmaceutical care for people in rural and remote communities.
Direct-to-Consumer Advertising in the Digital Age
This document discusses the increasing role of social media and the internet in the promotion of prescription drugs in Canada. It notes that pharmaceutical companies are shifting marketing budgets from traditional to digital channels due to cost pressures. The document outlines Canadian regulations around direct-to-consumer drug advertising and discusses concerns about the effects of such advertising. It also examines how pharmaceutical companies are using social media for targeted marketing and the lack of clear guidelines around these practices.
Webinar: Healthcare in the Federal Budget and How It May Affect Patients
Webinar: Healthcare in the Federal Budget and How It May Affect Patients Canadian Cancer Survivor Network
At this webinar, Steve Sampson (Global Public Affairs) discusses how the upcoming federal budget may contain announcements related to the way healthcare is funded in Canada, including changes to the regulation of pharmaceutical prices. Value for taxpayer money should always be the focus for government, but the need for cost-containment needs to be balanced with access to optimal healthcare innovation for patients.TELEPHARMACY
Telepharmacy involves the delivery of pharmaceutical care via telecommunications to patients who do not have direct contact with a pharmacist. It allows remote dispensing of medications and pharmacist monitoring of drug therapy. While telepharmacy improves access to care in remote areas by reducing travel requirements, it faces challenges in implementation due to lack of uniform regulations, technological limitations in rural areas, and changes to workflow. When actively involving pharmacists, telepharmacy can enhance quality of care by improving medication management and reducing errors.
Origin of healthcare funding models
The document summarizes healthcare systems in the United Kingdom and Germany. It discusses funding models for prescription drugs in England, including Clinical Commissioning Groups (CCGs) and the National Institute for Health and Care Excellence (NICE). It also describes the Cancer Drugs Fund in England and reforms to drug pricing in Germany under the AMNOG process.
LIMITATIONS
This study aimed to determine the barriers encountered by community pharmacists in Nigeria in providing pharmaceutical care. The study found that the key limitations reported by community pharmacists included: lack of skills in pharmaceutical care among pharmacists, poor attitudes towards pharmaceutical care practice, and resource and system-related constraints. Despite these limitations, most community pharmacists expressed strong willingness to adopt pharmaceutical care practices to improve patient outcomes. The study provides information to help address the gaps limiting wider implementation of pharmaceutical care in Nigeria.
Out of Box: Pharma Marketing
This document discusses direct-to-consumer (DTC) advertising of pharmaceutical products. It defines DTC advertising as marketing pharmaceutical products directly to consumers through various media like TV, print, radio, and social media. DTC advertising is meant to educate consumers about medical conditions and available treatments, and works in conjunction with doctors, not in isolation. The document also notes how new media and the internet have expanded consumers' access to health information and enabled the evolution of DTC advertising. Some examples of early DTC advertising campaigns for specific drugs are provided. The document concludes by discussing opportunities for the company Vasu to conduct DTC advertising through educational camps and seminars and targeted product leaflets.
Pain Med 2015 - Westanmo - Opioid Dose Reduction in a VA Health Care
The document describes an initiative at the Minneapolis VA Health Care System to reduce high-dose opioid prescribing through a population-level intervention in primary care. The initiative was associated with substantial reductions in the number of patients prescribed more than 200 mg morphine equivalents per day, from 342 patients (0.65% of unique pharmacy patients) before the initiative to 65 patients (0.12%) after. Overall opioid prescribing and doses also decreased over the study period. Provider surveys found increased agreement after the initiative that opioid dose limits and standards of care were important. The initiative demonstrated that leadership support, clinical pharmacy engagement, and monitoring and feedback to providers can successfully reduce high-dose opioid prescribing at a health system level.
Telepharmacy
The document discusses telepharmacy, which involves delivering pharmaceutical care via telecommunications to patients who may not have direct contact with a pharmacist. It provides an introduction to telepharmacy, outlines its objectives like improving access to healthcare and reducing costs. The document discusses the advantages and disadvantages of telepharmacy, and how it can be implemented. It then covers patient considerations, the process of starting a telepharmacy, license applications, how telepharmacy works, different types of telepharmacy models and concludes that telepharmacy can improve access to pharmaceutical care for rural communities.
Marketing and promotion_facts_071108_final
Pharmaceutical marketing to healthcare providers provides information on new treatment options, but it is only one of many factors that influence prescribing decisions. Surveys find clinical knowledge, patient factors, and insurance policies have greater impacts. Approximately 67% of US prescriptions are for generic drugs, much higher than other countries. While representatives provide information, prescribing is shaped more by clinical guidelines, peers, formularies, and insurers' prior authorization requirements than representative interactions.
Marketing and promotion_facts_071108_final
Pharmaceutical marketing aims to educate consumers and healthcare professionals about new treatments. While some question the value of marketing, it plays an important role in disseminating medical information. Recent changes include voluntary principles for direct-to-consumer ads and a strengthened industry code of ethics. Studies show marketing helps address underdiagnosis and undertreatment by raising disease awareness and prompting patients to see doctors. However, most physicians say clinical knowledge and patient needs strongly influence prescribing over marketing.
Inpud advocacy messsages to be delivered to the unodc meeting january 27 v2
The document discusses advocacy messages for a UNODC meeting on developing guidelines for stimulant use. It recommends:
1) Commending efforts to engage people who use drugs and conducting formative research to understand HIV outbreaks among stimulant users before developing guidelines.
2) Focusing on investigating the context of HIV outbreaks and using action research with clear peer support to understand what is happening.
3) Developing a comprehensive perspective that includes examining different stimulant users and factors contributing to their HIV risk separately.
Telepharmacy
Telepharmacy is delivery of pharmaceutical care via telecommunications to patients in locations where they may not have direct contact with pharmacist. It is an instance of wider phenomenon of telemedicine, as implemented in the field of pharmacy.
Telepharmacy services include drug therapy monitoring, patient counseling, monitoring of formulary compliance with the aid of teleconferencing or videoconferencing.
Telepharmacy services can be delivered at retail pharmacy sites or through hospitals, nursing homes or other medical care facilities.
Rural residents and communities lack easy access to healthcare services often due to geographical and demographical factors.
Telepharmacy holds significant promise as a technology to improve access to pharmaceutical care for people living in rural and remote communities.
Telepharmacy is quickly becoming an integral part of modern pharmacy practice that has the potential to provide quality pharmaceutical services, such as medication management, dispensing, patient counseling, and drug information.
Inherent to the adoption of these practices are legal challenges and pitfalls that need to be addressed. A well-developed system, however, can change the practice of pharmacy that is beneficial to both the rural communities and the hospital or retail pharmacies that deliver these services.
Speakers' bios
This document provides brief biographies of six panelists:
- Glen Doucet is Vice President of Advocacy at Canadian Pharmacists Association with over 23 years of experience in government relations.
- Louise Binder is a health advocate and lawyer who has worked to improve access to HIV/AIDS and cancer treatments for over 20 years.
- Marc-André Gagnon is an Associate Professor researching political economy of pharmaceutical sector including regulatory capture and innovation policy.
- Don Husereau is an Adjunct Professor focusing on evidence-based health policy and economics and chairs health technology assessment standards groups.
- W. Neil Palmer is president of a leading pricing and reimbursement consultancy and adjunct professor teaching on
Trudel Cms Rules 072810[1]
This document summarizes changes from the proposed rule to the final rule for Stage 1 of the Medicare and Medicaid EHR Incentive Program's meaningful use criteria. Key changes included lowering thresholds for some objectives, removing administrative transactions, adding new objectives, and modifying clinical quality measures for eligible professionals. The final rule provided more flexibility for states and clarified various eligibility and reporting requirements.
What's hot (19)
Tobacco cessation Therapy, India, Marketing strategy
Tobacco cessation Therapy, India, Marketing strategy
Patient Centricity in Pharmacovigilance: New Directions and New Horizons for ...
Patient Centricity in Pharmacovigilance: New Directions and New Horizons for ...
Il processo di innovazione in atto: dalle strategie di brevettazione al fundr...
Il processo di innovazione in atto: dalle strategie di brevettazione al fundr...
Webinar: Healthcare in the Federal Budget and How It May Affect Patients
Webinar: Healthcare in the Federal Budget and How It May Affect Patients
Pain Med 2015 - Westanmo - Opioid Dose Reduction in a VA Health Care
Pain Med 2015 - Westanmo - Opioid Dose Reduction in a VA Health Care
Inpud advocacy messsages to be delivered to the unodc meeting january 27 v2
Inpud advocacy messsages to be delivered to the unodc meeting january 27 v2
Viewers also liked
Rishi vis
This document presents Rishi Visual Identity System and includes examples of typefaces like Rish1,lead your life in different fonts of Times, Haettenschweiler, Constantia, Arial and Antiqua. It also lists the sales, public relations and logistics offices under the heading of invitation and VIP.
How i became the mayor of the west indian labor day parade
The document describes a mayor who mistakenly checked in too early for a Labor Day parade event on Foursquare. Though they checked in on the wrong date, many people still checked in. The mayor considers ways to make use of their position, such as coordinating meetups or providing tips for attendees. The implications suggest for event organizers to check in early to own the venue and provide useful tips for attendees to enhance their experience.
Engaging Mass Media in Communicating SRH Research in sub-Saharan Africa
This presentation was delivered by the African Population and Health Center to a workshop at the Liverpool School of Tropical Medicine on improving the use of research in policy and practice.
Women’s sexual and reproductive health – increasing the evidence base
The document discusses women's sexual and reproductive health issues in sub-Saharan Africa. It outlines high maternal mortality rates, low modern contraceptive use, high HIV prevalence disproportionately affecting women, and high rates of unsafe abortion and gender-based violence in the region. It also notes data and methodological challenges in studying these issues and proposes responses like integrating reproductive health services, prioritizing adolescents and unsafe abortion, and increasing domestic resource mobilization.
Goran Panel Bounfeng
The document discusses bridging the gap between research, policy, and practice in Laos. It outlines the current structure which involves research institutions conducting studies that are then disseminated to line ministries and the Ministry of Health to inform policy. However, there are still hindering factors such as limitations in research activities, insufficient funding, and a shortage of local researchers. Efforts are being made to improve utilizing evidence in policymaking, such as through health research forums and an evidence-informed policy network, but challenges remain in strengthening the use of research in Laos.
Viewers also liked (6)
How i became the mayor of the west indian labor day parade
How i became the mayor of the west indian labor day parade
Engaging Mass Media in Communicating SRH Research in sub-Saharan Africa
Engaging Mass Media in Communicating SRH Research in sub-Saharan Africa
Women’s sexual and reproductive health – increasing the evidence base
Women’s sexual and reproductive health – increasing the evidence base
Similar to FHS Nigeria
Making informal health providers work better for the poor: Lessons from Niger...
The document summarizes experiences with informal health providers in Nigeria and Bangladesh and lessons learned from interventions to improve their performance. In both countries, informal providers are an important source of healthcare for the poor but often provide low-quality and unnecessary treatment. Interventions involved training providers, establishing quality standards, and partnerships between organizations. This led to some improvements but also highlighted the need for sustainable business models and strategic leadership given political influences. Ongoing work includes learning platforms to further engage governments and improve market systems for the poor.
GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Gl...
The document discusses the growth of pharmacovigilance in India. It notes that while pharmacovigilance is still in its infancy in India, major advancements have been made in Western countries. It outlines the benefits of developing pharmacovigilance in India, including its large population and growing economy. Challenges to pharmacovigilance in India include its predominantly rural population, extensive use of traditional medicines, and lack of awareness among physicians and consumers. The document calls for building a more robust pharmacovigilance system in India through mandatory reporting, inspections, training programs, and collaborations.
Drug information centre resources@clinical pharmacy 4th pharm D
This document discusses drug information centers (DICs), including their establishment, personnel requirements, activities, challenges, and strategies to overcome challenges. It also discusses the role of pharmacists in DICs. DICs provide drug information to healthcare professionals and the public to promote safe and rational drug use. They require trained staff, resources, and standard operating procedures. Establishing DICs in hospitals can improve patient outcomes. Challenges include lack of awareness, funding, and trained professionals. Collaboration between healthcare groups can help address challenges and expand DIC services.
dic resources.pptx in pharmacoepidemiology
This document discusses drug information centers (DICs), including their establishment, personnel requirements, activities, challenges, and strategies to overcome challenges. It also discusses the role of pharmacists in DICs. DICs provide drug information to healthcare professionals and the public to promote safe and rational drug use. They require trained staff, resources, and standard operating procedures. Establishing DICs in hospitals can improve patient outcomes. Challenges include lack of awareness, funding, and trained professionals. Collaboration between healthcare groups can help address challenges and expand DIC services.
Governance transparency and accountability
'Governance transparency and accountability - role of civil society; MeTA objectives and approaches', presentation by Dr Daniel Kojo Arhinful during the MeTA Ghana, CSO & media orientation workshop, 16 April 2009.
Drug Purchasing & Pricing : industry perspective
This document summarizes a presentation given by David Lin from Novartis Oncology on drug purchasing and pricing from the pharmaceutical industry perspective. The presentation covers:
- The growing demand for healthcare and new treatments putting pressure on pricing and access
- Malaysia's national medicine policy and efforts to improve access to medicines through affordability
- Factors considered in pharmaceutical pricing like production costs, reference pricing to other countries, and balancing access and sustainability
- Efforts by industry like access programs to help patients gain early access to innovative treatments
- The changing treatment landscape with new cellular and personalized therapies requiring new frameworks for evaluation and pricing assessment.
Improving malaria diagnosis and treatment in the private retail sector in uga...
Presentation by Anthony Mbonye
Principal Investigator, ACT Consortium study in Uganda
Ministry of Health
Drug information services by BNP.pdf
It is defined as knowledge of fact through reading, study or practical experience on chemical substance that is used in diagnosis, prevention and treatment of diseases.
It covers all type of information including; objective and subjective information as well as information gathered by scientific observation or practical experience.
Agha Campaigns Sandra Kiapi
The document summarizes AGHA's advocacy campaigns in Uganda to promote access to essential medicines, including their "Stop-Stock-outs" campaign. It found frequent stock-outs of malaria and antibiotic drugs in rural health centers due to underfunding of the health sector. The campaign pressured the government and resulted in reports of shortages, commitments to purchase more drugs, and calls to increase health sector funding to 15% of the national budget.
Detecting Counterfeit Drugs through Mobile Authentication Service (MAS): Use...
International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online.
Rajasimha-ORDI-RareDiseasePolicy-ODA-Delhi-22Apr2016
This document discusses the Orphan Drug Act and rare disease policies. It provides background on the US Orphan Drug Act of 1983, which aims to facilitate rare disease drug development by providing incentives. Key points include that the Act defines rare diseases as affecting fewer than 200,000 people, and has led to over 450 approved orphan drugs. However, the document notes that rare disease policies and the Orphan Drug Act are not the same. It advocates for India to enact its own rare disease policies and definitions to improve diagnosis, treatment and research. The Organization for Rare Diseases India is working towards this goal.
Patient centered Pharmacovigilance .. .
Patient-centered pharmacovigilance represents a pivotal shift in the landscape of healthcare, emphasizing the active involvement of patients in the monitoring and reporting of adverse drug reactions. Unlike traditional pharmacovigilance, which primarily relies on healthcare professionals to identify and document adverse events, this approach recognizes patients as critical stakeholders in ensuring medication safety. By empowering patients to share their experiences, concerns, and observations regarding medication effects, whether positive or negative, healthcare systems can gain a comprehensive understanding of drug safety and efficacy in real-world settings. Patient-centered pharmacovigilance fosters a collaborative partnership between patients, healthcare providers, and regulatory agencies, promoting transparency, accountability, and ultimately, better patient outcomes. Through increased patient engagement and the utilization of patient-reported data, this approach enables healthcare systems to identify potential safety issues earlier, tailor treatment strategies to individual needs, and enhance overall drug safety surveillance efforts.
Opioid Epidemic - Causes, Impact and Future
In 2017, everyday, more than 130 people died in the US after overdosing on opioids. This document talks about America's worst drug crisis ever and shares how technology can play a role to cope up with this epidemic.
WHO Guideline of Medicine Policy.pdf
The document discusses WHO guidelines on rational medicine use and types of irrational medicine use. It notes that more than half of global medicine use is irrational, costing money and reducing treatment effectiveness. Irrational use includes polypharmacy, inappropriate antibiotic use, overuse of injections, and self-medication without prescriptions. The document lists several causes of irrational use, such as the natural history of illnesses, pseudo-logic, advertising influence on prescribers, and the perception that injections are always better than oral medications. Addressing irrational medicine use is important for improving health outcomes and efficient use of resources.
WHO PROMOTING rATIONAL USE OF MEDICINES.pdf
This document discusses policies and structures that can help promote rational use of medicines globally. It recommends several core interventions, including:
1) Establishing a mandated national body to coordinate medicine use policies involving various stakeholders.
2) Developing evidence-based clinical guidelines to provide treatment benchmarks and promote rational prescribing.
3) Creating essential medicines lists based on treatments of choice to focus procurement, prescribing, and public sector activities.
4) Forming drugs and therapeutics committees in districts and hospitals to promote safe and effective medicine use locally.
Together, such coordinated policies and oversight structures can help address the widespread problem of irrational global medicine use and its health and economic impacts.
Increasing access to medicines
Increasing access to medicines, presentation by Edith Andrews Annan of World Health Organization (WHO) during the MeTA Ghana, CSO & media orientation workshop, 16 April 2009.
Nandini vallathvienna final
WHO CC for Training and Policy on Access to Pain Relief, India
Side Event - International Doctors for Healthier Drug Policies
Commission on Narcotics Drugs, UN, Vienna
The Access and Delivery Partnership - New Health Technologies for TB, Malaria...
The Access and Delivery Partnership - New Health Technologies for TB, Malaria...UNDP HIV, Health and Development Practice
Presentation on the Access and Delivery Partnership by Tenu Avafia, 3 April 2014.
The presentation covered:
-Impact of NTDs, TB and Malaria on development outcomes;
-Dual challenges of Innovation and Access;
-Government of Japan and UNDP Partnership: Addressing innovation & Access
-Access and Delivery Partnership: strengthening capacity across the health system
Patient-Centered Pharmacovigilance
My talk at the Scientific Research Day of Medical colleges, UQU
5 March 2019
where I presented my publication (Patient-Centered Pharmacovigilance: A review)
Ippf webinar srh_hiv_pwud_27_aug2015
This document discusses addressing sexual and reproductive health (SRH) and HIV needs among key populations, specifically people who use drugs, in Kenya. It describes a project called "Shadows and Light" implemented by Family Health Options Kenya (FHOK) from 2012-2015, funded by IPPF and the German BACKUP Initiative, that aimed to strengthen SRH-HIV linkages for people who inject drugs. Key activities included training service providers, advocacy, and providing over 50,000 integrated SRH-HIV services to people who use drugs. Successes included higher retention of young people who use drugs in services, improved access to comprehensive care, and increased representation of people who use drugs in national HIV technical working groups. Ch
Similar to FHS Nigeria (20)
Making informal health providers work better for the poor: Lessons from Niger...
Making informal health providers work better for the poor: Lessons from Niger...
GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Gl...
GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Gl...
Drug information centre resources@clinical pharmacy 4th pharm D
Drug information centre resources@clinical pharmacy 4th pharm D
Improving malaria diagnosis and treatment in the private retail sector in uga...
Improving malaria diagnosis and treatment in the private retail sector in uga...
Detecting Counterfeit Drugs through Mobile Authentication Service (MAS): Use...
Detecting Counterfeit Drugs through Mobile Authentication Service (MAS): Use...
Rajasimha-ORDI-RareDiseasePolicy-ODA-Delhi-22Apr2016
Rajasimha-ORDI-RareDiseasePolicy-ODA-Delhi-22Apr2016
The Access and Delivery Partnership - New Health Technologies for TB, Malaria...
The Access and Delivery Partnership - New Health Technologies for TB, Malaria...
More from IDS
Building Institutions for an effective health system
This presentation was given by Gerald Bloom at the Global Symposium on Health Systems Research, November, 2010.
Analysis of cross-country changes in health services
This presentation was given in a session at the Global Symposium on Health Systems Research which was organised by the Future Health Systems Consortium. The author is Toru Matsubayashi from Johns Hopkins Bloomberg School of Public Health
The scale and scope of private contributions to health systems
This presentation was given at a session at the Global Symposium on Health Systems Research in November 2010. Panelists included Ruth Berg, Gerry Bloom, Birger Forsberg, Kara Hanson, Gina Lagomarsino, Dominic Montagu, Stefan Nachuk
Presentation on the literature review of interventions to improve health care...
This presentation was given in a Future Health System Consortium organised session at the Global Symposium on Health Systems Research in November 2010. The author is Alex Rowe from the Centers for Disease Control and Prevention.
Evidence on Improving Health Service Delivery in Developing Countries
This presentation by David Peters of the Future Health Systems Consortium was given at the Global Symposium on Health Systems Research in November 2010.
Pathways to Scaling up Health Services in Complex Adaptive Systems
This presentation by Ligia Paina & David Peters was given as part of a Future Health System Consortium session at the Global Symposium on Health Systems Research. It is part of our Beyond Scaling Up stream of work.
The Parliamentarians’ Perception of the Public Health Sector in Afghanistan
This document summarizes a survey of Afghan parliamentarians on their perceptions of the public health sector. Key findings include:
- Most parliamentarians agreed that the quality and amount of health services have improved but disagreed that people are happy with services or know what the Ministry is doing.
- Top health problems were seen as child health, maternal health, and mental health.
- Resources should focus on both rural and urban areas.
- User fees should not be implemented in clinics or hospitals.
- The health sector budget should be increased from 10% actual to 19% recommended.
Lessons Learned from Case Studies on Effective Service Delivery
This presentation by Katja Janovsky was given in a Future Health Systems Consortium session at the Global Symposium on Health System Research.
Learning by Doing and Applying our Learning
This presentation was given by Sara Bennett in a Future Health Systems Consortium session at the Global Symposium on Health System Research.
Institutional Analysis of the Ministry of Public Health at Central and Provin...
The document summarizes the findings of an institutional analysis of the Ministry of Public Health in Afghanistan at the central and provincial levels. It identifies strengths and challenges in key stewardship functions like setting strategies, developing technical guidelines, coordination, budgeting, monitoring and evaluation. It provides recommendations to address gaps in policies, guidelines, capacity and resources to help the Ministry strengthen its stewardship role over the health sector.
Implementing Rapid Medical Security reform in China: Importance of a Learning...
A presentation by Zhenzhong ZHANG and Yunping WANG of the China National Health Development Research Center. This was given at a Future Health Systems Consortium organised event at the Global Symposium on Health System Research.
From research to policy CNHDRC strategies
This presentation was given by Zhenzhong ZHANG and Yunping WANG of the China National Health Development Research Center at the Global Symposium on Health System Research.
Evaluation of health systems performance: the role of Health Systems Research
This presentation was given by Sara Bennett of the Future Health Systems Consortium at the Global Symposium on Health Systems Research.
Making the right to health a reality to Indigenous People in Brazil
The document summarizes Brazil's efforts to provide universal healthcare coverage, particularly for indigenous peoples, through its public health system (SUS). It discusses how the SUS expanded coverage from 1.1 million people in 1994 to 96.1 million in 2009, and reduced infant mortality rates from 47.1 to 19.3 per 1000 births from 1990 to 2007. It also notes indigenous peoples still face health inequities, with infant mortality rates of 22.9 for whites, 34.9 for blacks, and 51.14 for indigenous peoples. The document outlines Brazil's creation of an Indigenous Health Subsystem in 1999 to decentralize services and improve quality and access for indigenous communities, but notes challenges remain around uneven health gains and centralization.
Afghanistan Health Sector Balanced Scorecard
This presentation was given at the Global Symposium on Health System Research in November 2010. The authors are L P Singh, Olakunle Alonge, Anubhav Agarwal,
Kayhan Natiq, S D Gupta and David Peters.
What must be done? Capacity building for health systems research in low & mid...
This presentation was given in plenary by Sara Bennett of the Future Health Systems Consortium at the Global Symposium on Health Systems Research, November 2010.
What must be done to ehance capacity for health systems research?
This presentation was written by Sara Bennett, Ligia Paina, Christine Kim, Irene Agyepong, Somsak Chunharas, Di McIntyre and Stefan Nachuk for the Global Symposium on Health Systems Research, November, 2010.
IMPROVING HEALTH SERVICE DELIVERY IN DEVELOPING COUNTRIES: FROM EVIDENCE TO ...
This presentation was given by David Peters, Sameh El-Saharty, Banafsheh Siadat, Katja Janovsky, and Marko Vujicic at the Global Symposium on Health Systems Research, November 2010.
Pathways to scaling up health services Peters and Paina
This document discusses scaling up health services in complex adaptive systems. It argues that health systems behave like complex adaptive systems, characterized by heterogeneous actors that interact in dynamic and unpredictable ways. Scaling up is therefore not a linear or controlled process. The document outlines several concepts from complexity science that are relevant to scaling up, such as feedback loops, emergent behavior, tipping points, and path dependence. It suggests using theories and methods from complexity science to better understand scaling up and facilitate decision making. Key lessons are that scaling up requires flexibility, recognizing local conditions, and developing sustainable institutions over the long term through learning-based approaches.
Beyond technical solutions PRINN in Nigeria
The document summarizes a program in Northern Nigeria aimed at improving health outcomes through strengthening governance and service delivery. It discusses the political and historical context, outlines the program's goals and theories of change, describes early successes like establishing an integrated local health system board, and concludes that achieving health system reform requires addressing both technical and political factors through multifaceted engagement strategies tailored to the local context.
More from IDS (20)
Building Institutions for an effective health system
Building Institutions for an effective health system
Analysis of cross-country changes in health services
Analysis of cross-country changes in health services
The scale and scope of private contributions to health systems
The scale and scope of private contributions to health systems
Presentation on the literature review of interventions to improve health care...
Presentation on the literature review of interventions to improve health care...
Evidence on Improving Health Service Delivery in Developing Countries
Evidence on Improving Health Service Delivery in Developing Countries
Pathways to Scaling up Health Services in Complex Adaptive Systems
Pathways to Scaling up Health Services in Complex Adaptive Systems
The Parliamentarians’ Perception of the Public Health Sector in Afghanistan
The Parliamentarians’ Perception of the Public Health Sector in Afghanistan
Lessons Learned from Case Studies on Effective Service Delivery
Lessons Learned from Case Studies on Effective Service Delivery
Institutional Analysis of the Ministry of Public Health at Central and Provin...
Institutional Analysis of the Ministry of Public Health at Central and Provin...
Implementing Rapid Medical Security reform in China: Importance of a Learning...
Implementing Rapid Medical Security reform in China: Importance of a Learning...
Evaluation of health systems performance: the role of Health Systems Research
Evaluation of health systems performance: the role of Health Systems Research
Making the right to health a reality to Indigenous People in Brazil
Making the right to health a reality to Indigenous People in Brazil
What must be done? Capacity building for health systems research in low & mid...
What must be done? Capacity building for health systems research in low & mid...
What must be done to ehance capacity for health systems research?
What must be done to ehance capacity for health systems research?
IMPROVING HEALTH SERVICE DELIVERY IN DEVELOPING COUNTRIES: FROM EVIDENCE TO ...
IMPROVING HEALTH SERVICE DELIVERY IN DEVELOPING COUNTRIES: FROM EVIDENCE TO ...
Pathways to scaling up health services Peters and Paina
Pathways to scaling up health services Peters and Paina
Recently uploaded
Non-respiratory Functions of the Lungs.pdf
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
A Classical Text Review on Basavarajeeyam
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Physiology of Special Chemical Sensation of Taste
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Physiology of Chemical Sensation of smell.pdf
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Efficacy of Avartana Sneha in Ayurveda
Avartana Sneha is a unique method of Preparation of Sneha Kalpana in Ayurveda, mainly it is indicated for the Vataja rogas.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
STIs may cause PID. For the both disease, herbal medicine Fuyan Pill can be a solution.
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
PPT RELATED TO ARTHROLOGY ACCORDING TO NCISM AYURVEDA
Adhd Medication Shortage Uk - trinexpharmacy.com
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeProf. Marcus Renato de Carvalho
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Light House Retreats: Plant Medicine Retreat Europe
Our aim is to organise conscious gatherings and retreats for open and inquisitive minds and souls, with and without the assistance of sacred plants.
Recently uploaded (20)
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
FHS Nigeria
- 1. FHS Nigeria Oladimeji Oladepo January 12, 2009
- 9. Scoping studies-Results First Source of Treatment for Most Recent Episode of Malaria
- 10. 54 Different Types of Anti-malarial Drugs Found in Oyo, Enugu & Kaduna
- 11. Percent of Patent Medical Vendor Shops with Anti-Malarial Drugs
- 12. Mean Price of Malaria Brands